Viewing nowCombinationRisen Plus Tablets (Risendronate Sodium, Cholecalciferol)
Risedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.

MFDS item code 201004170 · Approved 2010.06.23 · Insurance code 641604720
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
This medication helps treat and prevent osteoporosis in postmenopausal women. It is also used to treat osteoporosis in men. Osteoporosis is a condition where bones become weak and can fracture easily, and this medication works to increase bone strength and prevent bone loss. Therefore, it is effective in reducing the risk of fractures due to osteoporosis. It is an important medication for maintaining bone health and preventing bone diseases. It is used for the treatment and prevention of osteoporosis.
Adults: Take 1 tablet orally once weekly No dosage adjustment is necessary in elderly patients (aged 60 years and older), since the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. No dosage adjustment is necessary in patients with creatinine clearance of 30ml/min or higher. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30ml/min. Food interferes with absorption of this medicine. To ensure adequate absorption, take it as follows. Take at least 30 minutes before breakfast, or at any time of day, at least 2 hours before or after eating or drinking. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking the medicine. Patients with inadequate dietary intake of calcium and vitamin D should take supplements. Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, residents of nursing homes, and patients with chronic diseases) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine provides one week's supply of 800 IU of vitamin D per day when taken once weekly. If a patient forgets to take the medicine on the scheduled day, take it on the day it is remembered. Take the next dose on the originally scheduled day. Do not take 2 tablets on the same day.
Safety and efficacy have not been established in children and growing adolescents.
This medication may irritate the gastrointestinal mucosa and can lead to esophageal reactions such as esophagitis, esophageal ulcers, and esophageal erosion when taken. Always take this medication with a sufficient amount of water, and do not lie down for at least 30 minutes after taking it. If experiencing difficulty swallowing, pain while swallowing, pain behind the sternum, or heartburn, stop taking the medication immediately and consult a doctor. Patients with problems in esophageal motility, hypocalcemia, or severe renal impairment should not take this medication. Patients with genetic issues such as lactose intolerance should also avoid it. Patients with allergies to Yellow No. 5 dye should take caution. Possible adverse reactions include dyspepsia, nausea, diarrhea, abdominal pain, muscle pain, joint pain, headache, dizziness, rash, among others. Regular check-ups are necessary as long-term use can decrease blood calcium and phosphorus levels. Rare side effects such as osteonecrosis of the jaw and external auditory canal osteonecrosis have been reported, thus oral hygiene care and attention during dental treatments are recommended. This medication's absorption may be hindered when taken with antacids or supplements containing calcium, magnesium, or iron, so it should be spaced apart. Women who are pregnant or breastfeeding should consult a doctor before taking this medication, and it is recommended to either discontinue breastfeeding or halt the administration of this medication. The safety for children has not been established, and elderly persons can take it without special caution. Symptoms of hypocalcemia may occur with overdose, necessitating immediate medical assistance, where gastric lavage or calcium supplementation may be performed if needed. This medication should be kept out of the reach of children, and changing the container is not recommended.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering. Additionally, it is recommended to store the medication in a place avoiding extreme heat or cold, preferably at normal indoor temperature between 1 and 30 degrees Celsius.
Light orange oval film-coated tablets
4 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Yu Young Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.